この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2026/7/161 分で読めます
Government Owned Invention Available for License: Method of Manufacturing Papilloma Infiltrating Lymphocyte (PIL) Cell Therapy Products as a Treatment for Patients With Chronic Viral Infection(s)
ローカル自動翻訳 · 情報源の原言語
概要
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for development of papilloma- infiltrating lymphocytes (PIL) as treatment for patients with chronic human papillomavirus (HPV) 6 or 11 infections.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →